Korsana Biosciences (KRSA) Research & Development (2018 - 2025)
Korsana Biosciences (KRSA) reported Research & Development of $348,000 for Q3 2025, up 329.6% from $81,000 a year earlier and up 521.4% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Research & Development (2018 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Korsana Biosciences' Research & Development came in at $496,000, up 95.3% year-over-year; for FY2024, it was $286,000, down 81.1% from FY2023.
- Research & Development has declined for five consecutive years, with a five-year compound annual growth rate of -68.7% (FY2019 to FY2024).
- By year, Research & Development came in at $1.52 million in FY2023 (-74.7%), $5.98 million in FY2022 (-84.1%), $37.64 million in FY2021 (-33.3%) and $56.41 million in FY2020 (-40.7%).
- The Q3 2025 figure ranks as the highest quarterly Research & Development since Q3 2023.
- Year over year, Research & Development gained in two of the last eight quarters, with growth averaging 6.6%.
- The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 329.6%); the low point was Q4 2023 (a decline of 98.0%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $56,000 (Q2 2025), $36,000 (Q1 2025) and $56,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Korsana Biosciences | 16.27 Mn | 1.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 348,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 44,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Sep 30, 2023 | 580,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 572,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 10.22 Mn |
| Mar 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 10.46 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 12.05 Mn |
| Mar 31, 2021 | 8.09 Mn |
| Dec 31, 2020 | 12.09 Mn |
API Access
Korsana Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();